MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression
Abstract Chronic inflammation promotes epigenetic reprogramming in cancer progression by pathways that remain unclear. The oncogenic MUC1-C protein is activated by the inflammatory NF-κB pathway in cancer cells. There is no known involvement of MUC1-C in regulation of the COMPASS family of H3K4 meth...
Main Authors: | Atrayee Bhattacharya, Atsushi Fushimi, Keyi Wang, Nami Yamashita, Yoshihiro Morimoto, Satoshi Ishikawa, Tatsuaki Daimon, Tao Liu, Song Liu, Mark D. Long, Donald Kufe |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-023-05395-9 |
Similar Items
-
MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells
by: Tatsuaki Daimon, et al.
Published: (2024-01-01) -
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells
by: Satoshi Ishikawa, et al.
Published: (2023-02-01) -
MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells
by: Nami Yamashita, et al.
Published: (2023-11-01) -
Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer
by: Nami Yamashita, et al.
Published: (2022-05-01) -
MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer
by: Kwok-Kin Wong, et al.
Published: (2021-01-01)